Use 96402 for prostate cancer drug administration even if patient brings in medication

Why This Topic Matters

The article helps readers understand a reimbursement-sensitive area where drug acquisition and administration may be handled differently, and where accurate code selection affects payment. It also provides context for Medicare policy references and quarterly drug pricing trends that may influence office workflow and billing decisions.

Article Sections

1. Billing prostate cancer drug administration when the patient brings the medication

   Introduces the reimbursement issue for in-office administration of prostate cancer-related therapy and frames the discussion around office billing practices and Medicare-related considerations.

2. Medicare-related exclusions and related injection coding

   Covers distinctions between administration scenarios tied to vaccines and other injectable therapies, along with references to related injection coding categories.

3. What is included in chemotherapy injection administration

   Summarizes the general service components discussed as part of chemotherapy administration reporting and the types of work bundled into the administration code family.

4. Urology drug fees for first quarter 2007

   Presents a quarterly fee table for multiple injectable and implantable drugs used in urology and related treatment settings, along with source attribution.